Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients.

TitleDecreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients.
Publication TypeJournal Article
Year of Publication2000
AuthorsBörner, GV, Zeviani, M, Tiranti, V, Carrara, F, Hoffmann, S, Gerbitz, KD, Lochmüller, H, Pongratz, D, Klopstock, T, Melberg, A, Holme, E, Pääbo, S
JournalHum Mol Genet
Volume9
Issue4
Pagination467-75
Date Published2000 Mar 01
ISSN0964-6906
KeywordsAcylation, Adult, Cell Line, Child, Preschool, Female, Humans, Hybrid Cells, Male, MELAS Syndrome, Middle Aged, Mitochondrial Encephalomyopathies, Oxidation-Reduction, Point Mutation, RNA, RNA, Transfer, Amino Acyl, RNA, Transfer, Asp, RNA, Transfer, Leu
Abstract

Mutations in human mitochondrial tRNA genes are associated with a number of multisystemic disorders. Using an assay that combines tRNA oxidation and circularization we have determined the relative amounts and states of aminoacylation of mutant and wild-type tRNAs in tissue samples from patients with MELAS syndrome (mito- chondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes) and MERRF syndrome (myoclonus epilepsy with ragged red fibers), respectively. In most, but not all, biopsies from MELAS patients carrying the A3243G substitution in the mitochondrial tRNA(Leu(UUR))gene, the mutant tRNA is under-represented among processed and/or aminoacylated tRNAs. In contrast, in biopsies from MERRF patients harboring the A8344G substitution in the tRNA(Lys)gene neither the relative abundance nor the aminoacylation of the mutated tRNA is affected. Thus, whereas the A3243G mutation may contribute to the pathogenesis of MELAS by reducing the amount of aminoacylated tRNA(Leu), the A8344G mutation does not affect tRNA(Lys)function in the same way.

DOI10.1093/hmg/9.4.467
Alternate JournalHum. Mol. Genet.
Citation Key10.1093/hmg/9.4.467
PubMed ID10699170
Grant List1180 / / Telethon / Italy